Top Biomed Stock Signal: STOK
Report Date: 03-17-2024
Symbol: STOK - Stoke Therapeutics, Inc.
Sector:
Industry:
Top Biomed Stock Signal: STOK
Stoke Therapeutics, Inc. (STOK)
3 Preston Ct
Bedford, MASSACHUSETTS 01730
Phone: 17814308200
Website: http://www.stoketherapeutics.com
CEO: Dr. Edward Kaye
NASDAQ, Nasdaq Global Select
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide medicines to treat the underlying causes of severe genetic diseases. Its lead product candidate, STK-001 used to treat Dravet syndrome, a severe and progressive genetic epilepsy. Stoke Therapeutics, Inc. has a partnership with Invitae Corporation to offer genetic testing. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was founded in 2014 and is headquartered in Bedford, Massachusetts.